International Journal of Infection

Published by: Kowsar

Engineering, Cloning and Expression of DNA Sequence Coding of OMP31 Epitope of Brucella melitensis linked to IL-2 in Escherichia coli

Narges Nazifi 1 , Mojtaba Tahmoorespur 1 , * , Mohammad Hadi Sekhavati 1 , ** , Alireza Haghparast 2 and Mohammad Ali Behroozikhah 3
Authors Information
1 Department of Animal, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, Iran
2 Department of Pathobiology, School of Veterinary Medicine, Ferdowsi University of Mashhad
3 Department of Brucellosis, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran
Corresponding Authors:
Article information
  • International Journal of Infection: July 2018, 5 (3); e68974
  • Published Online: July 2, 2018
  • Article Type: Research Article
  • Received: March 28, 2018
  • Revised: May 13, 2018
  • Accepted: May 15, 2018
  • DOI: 10.5812/iji.68974

To Cite: Nazifi N, Tahmoorespur M, Sekhavati M H, Haghparast A, Behroozikhah M A . Engineering, Cloning and Expression of DNA Sequence Coding of OMP31 Epitope of Brucella melitensis linked to IL-2 in Escherichia coli, Int J Infect. 2018 ; 5(3):e68974. doi: 10.5812/iji.68974.

Copyright © 2018, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 2010;140(3-4):392-8. doi: 10.1016/j.vetmic.2009.06.021. [PubMed: 19604656].
  • 2. Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, et al. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Infect Immun. 2005;73(12):8079-88. doi: 10.1128/IAI.73.12.8079-8088.2005. [PubMed: 16299302]. [PubMed Central: PMC1307072].
  • 3. Berzofsky JA. Intrinsic and extrinsic factors in protein antigenic structure. Science. 1985;229(4717):932-40. [PubMed: 2410982].
  • 4. Vizcaino N, Cloeckaert A, Zygmunt MS, Dubray G. Cloning, nucleotide sequence, and expression of the Brucella melitensis omp31 gene coding for an immunogenic major outer membrane protein. Infect Immun. 1996;64(9):3744-51. [PubMed: 8751924]. [PubMed Central: PMC174288].
  • 5. Wales JR, Baird MA, Davies NM, Buchan GS. Fusing subunit antigens to interleukin-2 and encapsulating them in liposomes improves their antigenicity but not their protective efficacy. Vaccine. 2005;23(17-18):2339-41. doi: 10.1016/j.vaccine.2005.01.040. [PubMed: 15755624].
  • 6. Werle M, Bernkop-Schnurch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids. 2006;30(4):351-67. doi: 10.1007/s00726-005-0289-3. [PubMed: 16622600].
  • 7. Tovey MG, Lallemand C. Adjuvant activity of cytokines. In: Gwyn D, editor. Vaccine Adjuvants. Springer; 2010. p. 287-309.
  • 8. Chen X, Zaro JL, Shen WC. Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev. 2013;65(10):1357-69. doi: 10.1016/j.addr.2012.09.039. [PubMed: 23026637]. [PubMed Central: PMC3726540].
  • 9. Amet N, Lee HF, Shen WC. Insertion of the designed helical linker led to increased expression of tf-based fusion proteins. Pharm Res. 2009;26(3):523-8. doi: 10.1007/s11095-008-9767-0. [PubMed: 19002568]. [PubMed Central: PMC3121561].
  • 10. nazifi N, Tahmoorespur M, Sekhavati MH, Haghparast A. Engineering of tandem repeat construction of experimental epitopes of OMP31 antigen from Brucella melitensis linked to interleukin2 as an adjuvant to produce recombinant vaccine for sheep. Seventh congress of animal science of Iran. Iran. 2016.
  • 11. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press; 1989.
  • 12. Yousefi S, Sekhavati MH, Abbassi Daloii T. Cloning and molecular characterization of Omp31 gene from Brucella melitensis Rev 1 strain. ARI. 2016;71.
  • 13. Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997;3(2):213-21. doi: 10.3201/eid0302.970219. [PubMed: 9204307]. [PubMed Central: PMC2627605].
  • 14. Ashford DA, di Pietra J, Lingappa J, Woods C, Noll H, Neville B, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22(25-26):3435-9. doi: 10.1016/j.vaccine.2004.02.041. [PubMed: 15308369].
  • 15. Yousefi S, Abbassi-Daloii T, Sekhavati MH, Tahmoorespur M. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen. Microb Pathog. 2018;115:50-6. doi: 10.1016/j.micpath.2017.12.045. [PubMed: 29253594].
  • 16. Skendros P, Boura P. Immunity to brucellosis. Rev Sci Tech. 2013;32(1):137-47. [PubMed: 23837372].
  • 17. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352(22):2325-36. doi: 10.1056/NEJMra050570. [PubMed: 15930423].
  • 18. Nelson BH. IL-2, regulatory T cells, and tolerance. J Immunol. 2004;172(7):3983-8.
  • 19. Yang-Snyder JA, Rothenberg EV. Spontaneous expression of interleukin-2 in vivo in specific tissues of young mice. Dev Immunol. 1998;5(4):223-45. [PubMed: 9814581]. [PubMed Central: PMC2275993].
  • 20. Pope B, Kent HM. High efficiency 5 min transformation of Escherichia coli. Nucleic Acids Res. 1996;24(3):536-7. [PubMed: 8602370]. [PubMed Central: PMC145660].
  • 21. Naghavi M, Sekhavati MH, Tahmoorespur M, Nassiry MR. Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen Against Brucella Infection. IRI. 2018;Inpress. doi: 10.22092/ARI.2017.110504.1131.
  • 22. Kreitman RJ. Immunotoxins in cancer therapy. Curr Opin Immunol. 1999;11(5):570-8.
  • 23. Rosano GL, Ceccarelli EA. Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol. 2014;5:172. doi: 10.3389/fmicb.2014.00172. [PubMed: 24860555]. [PubMed Central: PMC4029002].
  • 24. de Marco A, Deuerling E, Mogk A, Tomoyasu T, Bukau B. Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol. 2007;7:32. doi: 10.1186/1472-6750-7-32. [PubMed: 17565681]. [PubMed Central: PMC1904446].
  • 25. Forouharmehr A, Nassiri M, Govvati S, Javadmanesh A. Evaluation of Different Signal Peptides for Secretory Production of Recombinant Bovine Pancreatic Ribonuclease A in Gram Negative Bacterial System: an In silico Study. Curr Proteomics. 2017;14.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments